Literature DB >> 27422491

Group 2 innate lymphoid cells are increased in nasal polyps in patients with eosinophilic chronic rhinosinusitis.

Ichiro Tojima1, Hideaki Kouzaki2, Shino Shimizu2, Takao Ogawa2, Masahiko Arikata2, Hirohito Kita3, Takeshi Shimizu2.   

Abstract

ILC2s represent a critical innate cellular source of type 2 cytokines and may play important roles in various diseases. We examined the role of ILC2s in the pathogenesis of two subgroups of CRSwNP: ECRS and non-ECRS. We analyzed the prevalence of ILC2s in sinonasal tissues and in blood from patients with ECRS, non-ECRS, CRSsNP, and control. The prevalence of ILC2s in nasal tissues was higher in patients with ECRS as compared to those with non-ECRS or CRSsNP. The prevalence of blood ILC2s was not different between patients with ECRS and non-ECRS. The prevalence of blood ILC2s was higher in patients with allergic rhinitis and elevated serum IgE levels. Alternaria-induced IL-33 secretion was increased in nasal epithelial cells derived from patients with ECRS as compared to those from patients with non-ECRS or CRSsNP. ILC2s may be involved in the pathogenesis of CRSwNP, in particular in patients with tissue eosinophilia (i.e., ECRS).
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergic rhinitis; Alternaria; Asthma; Eosinophilic chronic rhinosinusitis; Group 2 innate lymphoid cells; IL-33

Mesh:

Substances:

Year:  2016        PMID: 27422491     DOI: 10.1016/j.clim.2016.07.010

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  13 in total

Review 1.  Group 2 Innate Lymphoid Cells in Airway Diseases.

Authors:  Atsushi Kato
Journal:  Chest       Date:  2019-05-10       Impact factor: 9.410

2.  ILCs and Allergy.

Authors:  Hiroki Kabata; Yasutaka Motomura; Tsuyoshi Kiniwa; Tetsuro Kobayashi; Kazuyo Moro
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 3.  Mechanisms and pathogenesis of chronic rhinosinusitis.

Authors:  Atsushi Kato; Robert P Schleimer; Benjamin S Bleier
Journal:  J Allergy Clin Immunol       Date:  2022-03-01       Impact factor: 14.290

Review 4.  Group 2 innate lymphoid cells in nasal polyposis.

Authors:  Whitney W Stevens; Atsushi Kato
Journal:  Ann Allergy Asthma Immunol       Date:  2020-08-08       Impact factor: 6.347

Review 5.  Roles of innate lymphoid cells (ILCs) in allergic diseases: The 10-year anniversary for ILC2s.

Authors:  Kathleen R Bartemes; Hirohito Kita
Journal:  J Allergy Clin Immunol       Date:  2021-05       Impact factor: 10.793

Review 6.  The Fate of Activated Group 2 Innate Lymphoid Cells.

Authors:  Laura Mathä; Itziar Martinez-Gonzalez; Catherine A Steer; Fumio Takei
Journal:  Front Immunol       Date:  2021-04-22       Impact factor: 7.561

Review 7.  Targetable pathogenic mechanisms in nasal polyposis.

Authors:  Alexander L Schneider; Robert P Schleimer; Bruce K Tan
Journal:  Int Forum Allergy Rhinol       Date:  2021-03-03       Impact factor: 5.426

8.  Elevated expression of IL-17RB and ST2 on myeloid dendritic cells is associated with a Th2-skewed eosinophilic inflammation in nasal polyps.

Authors:  Rui Zheng; Dan Wang; Kai Wang; Wen-Xiang Gao; Qin-Tai Yang; Li-Jie Jiang; Min Zhou; Yu-Jie Cao; Jianbo Shi; Yueqi Sun
Journal:  Clin Transl Allergy       Date:  2018-11-29       Impact factor: 5.871

Review 9.  Classification of chronic rhinosinusitis according to a nasal polyp and tissue eosinophilia: limitation of current classification system for Asian population.

Authors:  Sung-Woo Cho; Dae Woo Kim; Jeong-Whun Kim; Chul Hee Lee; Chae-Seo Rhee
Journal:  Asia Pac Allergy       Date:  2017-07-26

10.  Two Cases of Allergic Fungal Sinusitis with Differing Postoperative Course.

Authors:  Yuma Matsumoto; Hidenori Yokoi; Michitsugu Kawada; Masachika Fujiwara; Koichiro Saito
Journal:  Case Rep Otolaryngol       Date:  2019-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.